Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 10391
TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532469BDBM532469(US11214554, Compound I-24)
Affinity DataIC50: 5nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532465BDBM532465(US11214554, Compound I-20)
Affinity DataIC50: 8nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532469BDBM532469(US11214554, Compound I-24)
Affinity DataIC50: 8nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532485BDBM532485(US11214554, Compound I-40)
Affinity DataIC50: 12nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532485BDBM532485(US11214554, Compound I-40)
Affinity DataIC50: 12nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532465BDBM532465(US11214554, Compound I-20)
Affinity DataIC50: 18nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532495BDBM532495(US11214554, Compound I-50)
Affinity DataIC50: 21nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532472BDBM532472(US11214554, Compound I-27)
Affinity DataIC50: 26nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532495BDBM532495(US11214554, Compound I-50)
Affinity DataIC50: 28nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532487BDBM532487(US11214554, Compound I-42)
Affinity DataIC50: 28nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532449BDBM532449(US11214554, Compound I-5)
Affinity DataIC50: 32nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532497BDBM532497(US11214554, Compound INCB024360 | Epacadostat)
Affinity DataIC50: 32nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532497BDBM532497(US11214554, Compound INCB024360 | Epacadostat)
Affinity DataIC50: 33nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532460BDBM532460(US11214554, Compound I-16)
Affinity DataIC50: 35nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532488BDBM532488(US11214554, Compound I-43)
Affinity DataIC50: 35nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532456BDBM532456(US11214554, Compound I-12)
Affinity DataIC50: 35nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532468BDBM532468(US11214554, Compound I-23)
Affinity DataIC50: 36nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532487BDBM532487(US11214554, Compound I-42)
Affinity DataIC50: 36nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532436BDBM532436(US11214554, Compound I-2)
Affinity DataIC50: 38nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532468BDBM532468(US11214554, Compound I-23)
Affinity DataIC50: 38nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532488BDBM532488(US11214554, Compound I-43)
Affinity DataIC50: 38nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532472BDBM532472(US11214554, Compound I-27)
Affinity DataIC50: 42nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532476BDBM532476(US11214554, Compound I-31)
Affinity DataIC50: 42nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532460BDBM532460(US11214554, Compound I-16)
Affinity DataIC50: 42nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532436BDBM532436(US11214554, Compound I-2)
Affinity DataIC50: 43nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532456BDBM532456(US11214554, Compound I-12)
Affinity DataIC50: 43nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532492BDBM532492(US11214554, Compound I-47)
Affinity DataIC50: 47nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532492BDBM532492(US11214554, Compound I-47)
Affinity DataIC50: 48nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532482BDBM532482(US11214554, Compound I-37)
Affinity DataIC50: 53nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532449BDBM532449(US11214554, Compound I-5)
Affinity DataIC50: 58nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532467BDBM532467(US11214554, Compound I-22)
Affinity DataIC50: 64nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532475BDBM532475(US11214554, Compound I-30)
Affinity DataIC50: 65nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532491BDBM532491(US11214554, Compound I-46)
Affinity DataIC50: 65nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532494BDBM532494(US11214554, Compound I-49)
Affinity DataIC50: 66nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532470BDBM532470(US11214554, Compound I-25)
Affinity DataIC50: 68nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532486BDBM532486(US11214554, Compound I-41)
Affinity DataIC50: 69nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532493BDBM532493(US11214554, Compound I-48)
Affinity DataIC50: 72nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532483BDBM532483(US11214554, Compound I-38)
Affinity DataIC50: 78nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532489BDBM532489(US11214554, Compound I-44)
Affinity DataIC50: 78nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532474BDBM532474(US11214554, Compound I-29)
Affinity DataIC50: 80nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532368BDBM532368(US11214554, Compound I-1)
Affinity DataIC50: 80nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532458BDBM532458(US11214554, Compound I-14)
Affinity DataIC50: 81nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532466BDBM532466(US11214554, Compound I-21)
Affinity DataIC50: 82nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532481BDBM532481(US11214554, Compound I-36)
Affinity DataIC50: 82nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532496BDBM532496(US11214554, Compound I-51)
Affinity DataIC50: 83nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532453BDBM532453(US11214554, Compound I-9)
Affinity DataIC50: 85nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532461BDBM532461(US11214554, Compound I-17)
Affinity DataIC50: 85nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532454BDBM532454(US11214554, Compound I-10)
Affinity DataIC50: 90nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532471BDBM532471(US11214554, Compound I-26)
Affinity DataIC50: 92nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Nanjing Huawe Medicine Technology Group

US Patent
LigandChemical structure of BindingDB Monomer ID 532490BDBM532490(US11214554, Compound I-45)
Affinity DataIC50: 92nMAssay Description:1. Materials, Kits and EquipmentsSodium L-ascorbate (Cat: A4034-100G, SIGMA)4-(dimethylamino)benzaldehyde (Cat: 156477-25g, SIGMA)Trichloroacetic aci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: